服务热线: 020-82119606转601
关于我们 About us

        广州宏畅生物科技有限公司坐落于美丽的广州国际生物岛,是一家以人体组织器官的再生修复为目标,致力于生物人工医疗器械和组织工程产品的研发、生产和销售的高新技术企业。注册资金联合投资规模将达到2亿元。公司已建成符合国家规范的GMP标准厂房并取得国家医疗器械生产许可证。

       公司以产、学、研为基本模式,积极推动自主创新,并与中国人民解放军第三军医大学心血管再生医学团队实现全面合作。首席科学家朱楚洪教授长期致力于心血管再生医学和器官构建的研究,在该领域具有较高的学术地位。现任国家发展委组织工程国家地方联合工程实验室血管组织工程中心、血管植入物国家地方联合工程实验室人工血管中心、国家重点培育学科主任。

       公司多年来集研发与创新、转化与生产、产业与流通为一体,注重人才培养与团队打造,以市场为导向、产品为出口,不断攻克技术难关,现已研发出具有自主知识产权、处于国际领先水平的小口径生物人工血管,有望填补国内外在小口径血管修复替代治疗上的空白。此外公司将再生修复的核心技术运用于生物人工带瓣管道、生物人工角膜、新型生物美容产品、干细胞与组织工程联合治疗等的研发与生产。

       公司敏锐抓住“再生医学时代”的契机,瞄准市场对组织器官修复、再生与替代的迫切需求,以造福人类为宗旨,潜心产品研发,致力产品孵化,着力产品推出。以资本为纽带,以人才为动力,以科技为引领,公司正昂首走在生物再生医疗产品制造的星光大道上。

       Guangzhou-Hong Chang Biotechnology Co., Ltd. is situated in the beautiful Guangzhou international biological island. The goals of the company are regeneration of human tissue and organ repair. They are committed to the development of medical devices and bio-artificial tissue engineered production and marketing of high-tech enterprises. The registered capital of the joint investment will reach 200 million yuan. The company has built GMP standard factory buildings with national norms and has achieved national medical equipment production license.

       The company operates with production, learning and research as the basic model, actively promote independent innovation, and cooperate comprehensively with the Third Military Medical University cardiovascular regenerative medicine team. Chief scientist Professor Zhu Chuhong, who devoted his entire life to establish medical research and organ regeneration cardiovascular research, have high academic position in the field. He is currently the director of Center of Vascular Tssue Engineering in National& Regional Engineering Laboratory of Tissue Engineering, Center of Artificial Blood Vessels in National& Regional Vascular Graft and National Key Discipline Laboratory.

       The company has combined research, development with innovation, transformation with production, and industry with circulation as a whole for years. They concentrated on personnel training and team building, made the market-oriented products for export and constantly overcome technical difficulties. They have been developed internationally leading small-caliber biological artificial blood vessels with independent intellectual property rights, which are expected to fill gaps in the domestic and small-caliber vascular repair replacement therapy. In addition, the company will use core technology of regeneration and repair in the bio-artificial valve conduit, bio-artificial cornea, and new types of beauty products. Not to mention, the joint development and production of stem cell therapy and tissue engineering.

       The company keen to take advantages of the "Regenerative Medicine Time". They target the urgent needs of organ repair, regeneration and replacement in the market. The purpose is tantamount to benefit of human beings. They are determined to painstaking product development, product incubation efforts, and focus on product launch. They make use of capital as a link, talent as a driven, technology as a guide. The company is proudly walking on the avenue of biological regenerative medical product manufacturing.

 

 广州宏畅生物科技有限公司     广州市国际生物岛螺旋四路一号生产区第二层201单元  
犀牛云提供企业云服务
地址:中国·深圳·宝安中心区·宝源路F518时尚创意园15栋3层
电话:020-82119606转601
邮箱:hcsw709@163.com
邮编:330520